Close

Pre-Open Movers 07/03: (OPXA) (EYES) (RATE) Higher; (RICE) (AVAV) (MLCO) Lower (more...) Jul 3, 2017 09:23AM
Opexa Therapeutics to Present at Rodman & Renshaw 18th Annual Global Investment Conference Sep 7, 2016 08:30AM
Opexa Therapeutics Reports Second Quarter 2016 Financial Results and Provides Corporate Update Aug 11, 2016 04:01PM
Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss Second Quarter 2016 Financial Results Aug 9, 2016 08:30AM
Opexa Therapeutics Reports First Quarter 2016 Financial Results and Provides Corporate Update May 12, 2016 04:01PM


May 10, 2016 09:00AM Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss First Quarter 2016 Financial Results
Apr 27, 2016 08:30AM Opexa to Attend the Third International Conference on the Progress of Regenerative Medicine and Its Cultural Impact
Mar 15, 2016 04:01PM Opexa Therapeutics Reports 2015 Year End Financial Results and Provides Corporate Update
Mar 14, 2016 09:00AM Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss Year End 2015 Financial Results
Mar 2, 2016 04:03PM Opexa Therapeutics (OPXA) Announces Restructuring Initiative
Mar 2, 2016 04:00PM Opexa Launches Restructuring Initiative to Focus Use of Resources Ahead of Key Phase 2 Data Expected in Early Q4 2016
Jan 28, 2016 09:00AM Opexa Therapeutics to Present at the 18th Annual BIO CEO and Investor Conference
Nov 17, 2015 08:00AM Opexa Therapeutics Chosen as One of the Top Autoimmune Therapy Projects to Watch
Nov 10, 2015 04:05PM Opexa Therapeutics Announces Supportive Preclinical Study Results for its Neuromyelitis Optica (NMO) Program
Nov 10, 2015 04:01PM Opexa Therapeutics Reports Third Quarter 2015 Financial Results and Provides Corporate Update
Nov 6, 2015 08:30AM Opexa Therapeutics Announces News Release Schedule for Third Quarter 2015 Financial Results
Oct 19, 2015 08:11AM Opexa Therapeutics to Host Analyst and Investor Event on November 10 in New York
Oct 15, 2015 08:00AM Opexa Therapeutics Regains Compliance with NASDAQ Minimum Bid Price Listing Requirement
Oct 13, 2015 07:00AM Opexa Therapeutics to Present at BIO Investor Forum
Oct 6, 2015 07:00AM Opexa Announces Granting of New T-cell Patents Covering Tcelna®; Patent Estate Increases to 160 Issued Patents
Sep 28, 2015 07:00AM Opexa Announces Reverse Stock Split
Sep 1, 2015 06:00AM Opexa Secures Private Funding for its NMO Orphan Development Program, Including Planned Phase I/II Clinical Study
Aug 28, 2015 09:00AM Opexa Therapeutics to Present at September Conferences
Aug 12, 2015 04:02PM Opexa Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update
Aug 3, 2015 07:00AM Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss Second Quarter 2015 Financial Results